Effect Of A Treatment Optimization Program To Improve Satisfaction With Viagra
Sponsor
Pfizer (Industry)
Overall Status
Completed
CT.gov ID
NCT00159848
Collaborator
(none)
8,000
Study Details
Study Description
Brief Summary
This study will demonstrate if a treatment optimization program has an impact on the satisfaction with Viagra treatment in men with erectile dysfunction
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Phase 4 |
Study Design
Study Type:
Interventional
Allocation:
Non-Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Official Title:
Effectiveness Of An Educational Program To Improve Patients' Satisfaction Regarding Their Management Of Erectile Dysfunction With Sildenafil
Study Start Date
:
Sep 1, 2003
Actual Primary Completion Date
:
Sep 1, 2003
Actual Study Completion Date
:
Sep 1, 2003
Outcome Measures
Primary Outcome Measures
- Assess the impact of a sildenafil educational program versus usual care on subjects' satisfaction regarding their management of ED with sildenafil as assessed through the validated EDITS questionnnaire after 3 months of treatment []
Secondary Outcome Measures
- Describe the relationship between the administration of an educational program and the effectiveness of sildenafil; Evaluate the educational program as a tool to help physicians in their management of ED; Estimate the intracluster correlation coefficient []
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Male subjects above age of majority for whom sildenafil is prescribed for the first time within the usual practice of medicine
Exclusion Criteria:
-
Male subjects who have used any ED medical treatments over the last month, with the exception of testosterone and/or herbal therapies
-
Subjects who do not have the possibility of viewing the video either through a computer, VCR or a DVD
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Pfizer
Investigators
- Study Director: Pfizer CT.gov Call Center, Pfizer
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Pfizer
ClinicalTrials.gov Identifier:
NCT00159848
Other Study ID Numbers:
- NRA1481115
First Posted:
Sep 12, 2005
Last Update Posted:
May 3, 2013
Last Verified:
May 1, 2013
Additional relevant MeSH terms: